Office of HIV/AIDS, United States Agency for International Development, Washington DC, USA
Research Article
Robust Progress in ARV Optimization for Adolescents and Adults in PEPFAR Partner Countries during the First Years of COVID−19
Author(s): Rachel A. Golin*, Miriam M. Hartig, B. Ryan Phelps, Dessalegn Tesfaye, Jeffrey M. Samuel, Christine Y. Malati, Katelyn A. Morgan and George K. Siberry
Problem: The United States President’s Emergency Plan for AIDS Relief (PEPFAR) partner countries have been directly impacted by multiple waves of COVID-19 since early 2020. The HIV global supply chain in particular experienced drastic manufacturing and logistic disruptions. This public health crisis has tested the resilience of national HIV programs as ministries of health (MoH) and donors worked to maintain HIV programs while implementing COVID-19 readiness and response actions. Our goal was to assess progress in dolutegravir (DTG) transition for adolescent and adult populations during COVID-19.
Local Setting: Sixteen countries that receive support from PEPFAR, through the United States Agency for International Development (USAID), met the following inclusion criteria during both six month reporting periods (October 2019 - March 2020 .. Read More»
DOI:
10.37421/2155-6113.2023.14.926
Journal of AIDS & Clinical Research received 5264 citations as per Google Scholar report